Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Aileron Therapeutics, Inc. Common Stock (ALRN)
Pharmaceutical Preparations
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.
738 MAIN STREET, UNIT 398
WALTHAM, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/29/2017
Market Cap
42,148,860
Shares Outstanding
4,890,000
Weighted SO
4,885,733
Total Employees
N/A
Upcoming Earnings
08/09/2024
Beta
2.2220
Last Div
0.0000
Range
1.01-7.42
Chg
0.3000
Avg Vol
67696
Mkt Cap
42148860
Exch
NASDAQ
Country
US
Phone
617 995 0900
DCF Diff
4.7863
DCF
0.0038
Div Yield
0.0000
P/S
314.5437
EV Multiple
-0.7940
P/FV
0.3843
Div Yield %
0.0000
P/E
-1.5395
PEG
-0.0362
Payout
0.0000
Current Ratio
4.6909
Quick Ratio
4.6909
Cash Ratio
4.4444
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
2247.4803
CCC
-2247.4803
Gross Margin
0.0522
Op Margin
-190.5149
Pretax Margin
-188.2164
Net Margin
-188.2164
Eff Tax Rate
-0.0148
ROA
-0.2305
ROE
-0.4794
ROCE
-0.2444
NI/EBT
1.0000
EBT/EBIT
0.9879
EBIT/Rev
-190.5149
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
12.4897
CF/Debt
0.0000
Equity Multi
1.0829
Rec Turnover
0.0000
Pay Turnover
0.1624
Inv Turnover
0.0000
FA Turnover
67.0000
Asset Turnover
0.0012
OCF/Share
-1.2903
FCF/Share
-1.2903
Cash/Share
1.1020
OCF/Sales
-191.7239
FCF/OCF
1.0000
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
0.3843
P/B
0.3843
P/S
314.5437
P/E
-1.5395
P/FCF
-1.6406
P/OCF
-1.5113
P/CF
-1.5113
PEG
-0.0362
P/S
314.5437
EV Multiple
-0.7940
P/FV
0.3843
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
400.00 Shares Bought (99.75 %)
0.00 Shares Sold (0.25%)
3 - 6 Months
692.50K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
13.63K Shares Bought (23.81 %)
43.59K Shares Sold (76.19%)
9 - 12 Months
2.00K Shares Bought (0.46 %)
428.99K Shares Sold (99.54 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 134.00K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 43.00K | ▲ 52.00K | ▲ 59.00K |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -43.00K | ▲ 82.00K | ▼ -59.00K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.61 | ▼ 0.00 |
Research And Development Expenses | 3.96M | ▲ 4.71M | ▼ 1.93M | ▲ 4.56M | ▼ 2.40M | ▼ 1.97M | ▲ 3.46M |
General And Administrative Expenses | 3.02M | ▼ 2.64M | ▼ 2.27M | ▼ 2.26M | ▲ 2.30M | ▲ 5.33M | ▼ 3.74M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -52.00K | ▲ 0.00 |
Selling General And Administrative Expenses | 3.02M | ▼ 2.64M | ▼ 2.27M | ▼ 2.26M | ▲ 2.30M | ▲ 5.28M | ▼ 3.74M |
Other Expenses | 0.00 | 0.00 | 0.00 | ▲ 71.00K | ▲ 336.00K | ▲ 657.00K | ▼ 92.00K |
Operating Expenses | 6.98M | ▲ 7.35M | ▼ 4.19M | ▲ 6.82M | ▼ 4.70M | ▲ 7.25M | ▼ 7.21M |
Cost And Expenses | 6.98M | ▲ 7.35M | ▼ 4.19M | ▲ 6.82M | ▼ 4.70M | ▲ 7.30M | ▼ 7.21M |
Interest Income | -52.00K | ▲ 114.00K | ▼ -77.00K | ▲ -54.00K | ▼ -180.00K | ▲ 78.00K | ▼ 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -180.00K | ▼ -2.04M | ▲ 0.00 |
Depreciation And Amortization | 49.00K | ▲ 75.00K | ▼ 10.00K | ▲ 40.00K | ▲ 43.00K | ▲ 52.00K | ▲ 59.00K |
Ebitda | -6.93M | ▼ -7.27M | ▲ -3.46M | ▼ -6.78M | ▲ -4.66M | ▼ -7.25M | ▲ -7.21M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -54.10 | ▲ 0.00 |
Operating Income | -6.98M | ▼ -7.35M | ▲ -4.19M | ▼ -6.82M | ▲ -4.70M | ▼ -7.30M | ▲ -7.21M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -54.49 | ▲ 0.00 |
Total Other Income Expenses Net | -52.00K | ▲ 114.00K | ▼ -727.00K | ▲ 30.00K | ▲ 156.00K | ▼ -37.00K | ▲ 92.00K |
Income Before Tax | -7.03M | ▼ -7.24M | ▲ -5.00M | ▼ -6.84M | ▲ -4.55M | ▼ -7.34M | ▲ -7.11M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -54.77 | ▲ 0.00 |
Income Tax Expense | 0.00 | 0.00 | ▲ 804.00K | ▼ 13.00K | ▼ -156.00K | ▲ 581.00K | ▼ -59.00K |
Net Income | -7.03M | ▼ -7.24M | ▲ -5.00M | ▼ -6.80M | ▲ -4.39M | ▼ -7.34M | ▲ -7.11M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -54.77 | ▲ 0.00 |
Eps | -9.60 | ▲ -5.00 | ▲ -2.40 | ▲ -1.49 | ▲ -0.97 | ▼ -1.54 | ▲ -0.86 |
Eps Diluted | -9.60 | ▲ -5.00 | ▲ -2.40 | ▲ -1.49 | ▲ -0.97 | ▼ -1.54 | ▲ -0.86 |
Weighted Average Shs Out | 737.29K | ▲ 1.39M | ▲ 1.85M | ▲ 4.53M | ▲ 4.54M | ▲ 4.77M | ▲ 8.30M |
Weighted Average Shs Out Dil | 737.29K | ▲ 1.39M | ▲ 1.85M | ▲ 4.53M | ▲ 4.54M | ▲ 4.77M | ▲ 8.30M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 10.64M | ▼ 5.31M | ▲ 7.05M | ▼ 3.60M | ▲ 5.19M | ▲ 17.34M | ▼ 12.07M |
Short Term Investments | 10.06M | ▲ 12.97M | ▼ 6.76M | ▲ 42.33M | ▼ 16.05M | ▼ 0.00 | 0.00 |
Cash And Short Term Investments | 20.70M | ▼ 18.28M | ▼ 13.81M | ▲ 45.93M | ▼ 21.24M | ▼ 17.34M | ▼ 12.07M |
Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 1.06M | ▲ 1.25M | ▲ 1.93M | ▲ 2.22M | ▼ 606.00K | ▲ 928.00K | ▼ 697.00K |
Total Current Assets | 21.78M | ▼ 19.55M | ▼ 16.33M | ▲ 48.18M | ▼ 21.87M | ▼ 18.27M | ▼ 12.76M |
Property Plant Equipment Net | 7.29M | ▼ 6.36M | ▼ 15.00K | ▲ 280.00K | ▼ 110.00K | ▼ 19.00K | ▼ 6.00K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 6.33M | 6.33M |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 79.20M | 79.20M |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 85.53M | 85.53M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 13.28M | ▼ 0.00 |
Other Non Current Assets | 1.25M | ▼ 568.00K | ▼ 0.00 | ▲ 24.00K | 24.00K | ▲ 2.19M | ▼ 892.00K |
Total Non Current Assets | 8.54M | ▼ 6.92M | ▼ 15.00K | ▲ 304.00K | ▼ 134.00K | ▲ 101.02M | ▼ 86.43M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 30.31M | ▼ 26.47M | ▼ 16.34M | ▲ 48.48M | ▼ 22.01M | ▲ 119.29M | ▼ 99.19M |
Account Payables | 1.73M | ▼ 1.45M | ▲ 1.60M | ▼ 1.21M | ▲ 1.72M | ▼ 1.19M | ▲ 2.16M |
Short Term Debt | 0.00 | ▲ 446.00K | ▼ 168.00K | ▼ 93.00K | ▼ 33.00K | ▲ 48.00K | ▼ 0.00 |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | ▲ 3.59M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 3.64M | ▼ 352.00K | ▲ 2.20M | ▲ 3.21M | ▼ 1.63M | ▲ 3.15M | ▼ 2.38M |
Total Current Liabilities | 5.37M | ▲ 5.84M | ▼ 3.96M | ▲ 4.51M | ▼ 3.38M | ▲ 4.39M | ▲ 4.53M |
Long Term Debt | 5.34M | ▼ 4.59M | ▼ 219.00K | ▼ 69.00K | ▼ 33.00K | ▲ 91.41M | ▼ 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 16.60M | ▼ 3.33M |
Other Non Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.72M | ▼ 0.00 | ▼ -1.00 |
Total Non Current Liabilities | 5.34M | ▼ 4.59M | ▼ 219.00K | ▼ 69.00K | ▲ 1.75M | ▲ 108.01M | ▼ 3.33M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.75M | ▲ 0.00 | ▲ 1.00 |
Capital Lease Obligations | 5.34M | ▼ 5.03M | ▼ 0.00 | ▲ 162.00K | ▼ 33.00K | ▲ 48.00K | ▼ 0.00 |
Total Liabilities | 10.71M | ▼ 10.43M | ▼ 4.18M | ▲ 4.58M | ▼ 3.38M | ▲ 112.40M | ▼ 7.86M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 91.41K | ▲ 46.58M |
Common Stock | 15.00K | ▲ 28.00K | ▲ 44.00K | ▲ 91.00K | 91.00K | 91.00K | ▲ 103.00K |
Retained Earnings | -168.49M | ▼ -198.14M | ▼ -219.29M | ▼ -245.46M | ▼ -272.79M | ▼ -288.52M | ▼ -295.63M |
Accumulated Other Comprehensive Income Loss | -5.00K | ▲ 7.00K | ▼ -2.00K | ▼ -13.00K | ▼ -48.00K | ▼ -63.00K | -63.00K |
Other Total Stockholders Equity | 188.08M | ▲ 214.15M | ▲ 231.41M | ▲ 289.28M | ▲ 291.37M | ▲ 295.28M | ▲ 340.34M |
Total Stockholders Equity | 19.60M | ▼ 16.05M | ▼ 12.16M | ▲ 43.90M | ▼ 18.62M | ▼ 6.89M | ▲ 91.33M |
Total Equity | 19.60M | ▼ 16.05M | ▼ 12.16M | ▲ 43.90M | ▼ 18.62M | ▼ 6.89M | ▲ 91.33M |
Total Liabilities And Stockholders Equity | 30.31M | ▼ 26.47M | ▼ 16.34M | ▲ 48.48M | ▼ 22.01M | ▲ 119.29M | ▼ 99.19M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 30.31M | ▼ 26.47M | ▼ 16.34M | ▲ 48.48M | ▼ 22.01M | ▲ 119.29M | ▼ 99.19M |
Total Investments | 10.06M | ▲ 12.97M | ▼ 6.76M | ▲ 42.33M | ▼ 16.05M | ▼ 0.00 | 0.00 |
Total Debt | 5.34M | ▼ 5.03M | ▼ 387.00K | ▼ 162.00K | ▼ 33.00K | ▲ 91.46M | ▼ 0.00 |
Net Debt | -5.29M | ▲ -279.00K | ▼ -6.66M | ▲ -3.44M | ▼ -5.16M | ▲ 74.12M | ▼ -12.07M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -7.03M | ▼ -7.24M | ▲ -5.00M | ▼ -6.80M | ▲ -4.55M | ▼ -7.34M | ▲ -7.11M |
Depreciation And Amortization | 49.00K | ▲ 75.00K | ▼ 10.00K | ▲ 40.00K | ▲ 43.00K | ▲ 52.00K | ▲ 59.00K |
Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -4.12M | ▲ 0.00 |
Stock Based Compensation | 591.00K | ▼ 479.00K | ▼ 363.00K | ▲ 607.00K | ▼ 424.00K | ▼ 270.00K | ▼ 150.00K |
Change In Working Capital | -211.00K | ▲ 432.00K | ▼ -56.00K | ▼ -131.00K | ▼ -206.00K | ▼ -3.55M | ▲ 1.63M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | 174.00K | ▼ -880.00K | ▲ 567.00K | ▼ 178.00K | ▲ 775.00K | ▼ -3.75M | ▲ 966.00K |
Other Working Capital | -385.00K | ▲ 1.31M | ▼ -623.00K | ▲ -309.00K | ▼ -981.00K | ▲ 194.00K | ▲ 667.00K |
Other Non Cash Items | -58.00K | ▲ -56.00K | ▲ -10.00K | ▲ 28.00K | ▼ -123.00K | ▲ 4.30M | ▼ -698.00K |
Net Cash Provided By Operating Activities | -6.66M | ▲ -6.31M | ▲ -4.69M | ▼ -6.26M | ▲ -4.41M | ▼ -10.39M | ▲ -5.27M |
Investments In Property Plant And Equipment | -1.93M | ▲ -15.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -96.00K | ▲ 0.00 |
Purchases Of Investments | -4.96M | ▲ -2.73M | ▲ -2.00M | ▼ -2.75M | ▲ -1.94M | ▲ 0.00 | 0.00 |
Sales Maturities Of Investments | 15.20M | ▼ 7.51M | ▼ 1.50M | ▲ 5.00M | ▲ 6.70M | ▼ 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | ▲ 142.00K | ▼ 0.00 | ▲ 4.76K | ▲ 42.00K | ▼ 0.00 |
Net Cash Used For Investing Activities | 8.31M | ▼ 4.76M | ▼ -357.00K | ▲ 2.25M | ▲ 4.76M | ▼ -96.00K | ▲ 0.00 |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -33.00K | ▲ 0.00 |
Common Stock Issued | 42.00K | ▼ -15.00K | ▲ 4.24M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 1.24M | ▼ 0.00 | ▲ 3.00K | ▼ 1.00K | ▼ 0.00 | ▲ 15.79M | ▼ 0.00 |
Net Cash Used Provided By Financing Activities | 1.28M | ▼ -15.00K | ▲ 4.24M | ▼ 1.00K | ▼ 0.00 | ▲ 15.79M | ▼ 0.00 |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -63.00K | ▲ 0.00 |
Net Change In Cash | 2.92M | ▼ -1.56M | ▲ -804.00K | ▼ -4.00M | ▲ 355.00K | ▲ 5.24M | ▼ -5.27M |
Cash At End Of Period | 11.23M | ▼ 5.90M | ▲ 7.64M | ▼ 3.63M | ▲ 5.22M | ▲ 17.34M | ▼ 12.07M |
Cash At Beginning Of Period | 8.31M | ▼ 7.46M | ▲ 8.44M | ▼ 7.63M | ▼ 4.86M | ▲ 12.09M | ▲ 17.34M |
Operating Cash Flow | -6.66M | ▲ -6.31M | ▲ -4.69M | ▼ -6.26M | ▲ -4.41M | ▼ -10.39M | ▲ -5.27M |
Capital Expenditure | -1.93M | ▲ -15.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow | -8.60M | ▲ -6.32M | ▲ -4.69M | ▼ -6.26M | ▲ -4.41M | ▼ -10.39M | ▲ -5.27M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)